Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14825-82-2

Post Buying Request

14825-82-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14825-82-2 Usage

Uses

(S)-4-Benzyloxazolidine-2,5-dione, can be used in the synthesis of amphiphilic anionic copolymer, methoxy poly(ethylene glycol)-b-poly(l-glutamic acid-co-l-phenylalanine) (mPEG-b-P(Glu-co-Phe)), used as an efficient drug delivery system for an anticancer drug doxorubicin hydrochloride (DOX·HCl).

Check Digit Verification of cas no

The CAS Registry Mumber 14825-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,8,2 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 14825-82:
(7*1)+(6*4)+(5*8)+(4*2)+(3*5)+(2*8)+(1*2)=112
112 % 10 = 2
So 14825-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO3/c12-9-8(11-10(13)14-9)6-7-4-2-1-3-5-7/h1-5,8H,6H2,(H,11,13)/t8-/m0/s1

14825-82-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (4S)-4-benzyl-1,3-oxazolidine-2,5-dione

1.2 Other means of identification

Product number -
Other names Phenylalanine NCA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14825-82-2 SDS

14825-82-2Synthetic route

oxalyl dichloride
79-37-8

oxalyl dichloride

C20H33NO4Si
130529-77-0

C20H33NO4Si

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With N,N-dimethyl-formamide In dichloromethane at 0 - 20℃;100%
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

L-phenylalanine sodium salt
16480-57-2

L-phenylalanine sodium salt

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With 4-methyl-morpholine In water; acetonitrile at 20℃; for 0.00277778h; Reagent/catalyst; Flow reactor; Inert atmosphere;100%
Stage #1: bis(trichloromethyl) carbonate; L-phenylalanine sodium salt With 4-methyl-morpholine In water; acetonitrile at 20℃; for 2.77778E-05h;
Stage #2: In water; ethyl acetate; acetonitrile at 20℃; for 0.000261111h; Solvent; Reagent/catalyst;
100%
N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With phosphorus trichloride In dichloromethane at 0℃; for 2h;98%
With bis(trichloromethyl) carbonate; triethylamine In ethyl acetate Ambient temperature;75%
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

L-phenylalanine
63-91-2

L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran at 50℃;94%
In tetrahydrofuran at 40℃; Inert atmosphere;91.5%
In tetrahydrofuran at 50℃; Inert atmosphere;84%
1,1,1,3,3,3-hexachloro-propan-2-one
116-16-5

1,1,1,3,3,3-hexachloro-propan-2-one

L-phenylalanine
63-91-2

L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran at 50℃; Inert atmosphere;91.5%
phosgene
75-44-5

phosgene

L-phenylalanine
63-91-2

L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran; toluene at 50℃; for 1h;86%
In tetrahydrofuran; toluene at 50℃; for 1.5h;86%
L-phenylalanine
63-91-2

L-phenylalanine

trichloromethyl chloroformate
503-38-8

trichloromethyl chloroformate

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With pyrographite In tetrahydrofuran at 55℃; for 0.5h;86%
In tetrahydrofuran at 40 - 50℃; for 3h;42.8%
In tetrahydrofuran phosgenation;
N-phenoxycarbonyl-L-phenylalanine

N-phenoxycarbonyl-L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
Stage #1: N-phenoxycarbonyl-L-phenylalanine With acetic acid In acetonitrile at 80℃; Inert atmosphere;
Stage #2: With hydrogenchloride In water; acetonitrile at 20℃; for 1h; Inert atmosphere;
78%
N-Cbz-L-Phe
1161-13-3

N-Cbz-L-Phe

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With 1-pyrrolidinecarboxaldehyde; 1,3,5-trichloro-2,4,6-triazine In acetonitrile at 20℃; for 8h;69%
N-methoxycarbonyl-L-phenylalanine
41844-91-1

N-methoxycarbonyl-L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With phosphorus tribromide In diethyl ether66.8%
chloroform
67-66-3

chloroform

L-phenylalanine
63-91-2

L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With 4-methyl-morpholine; oxygen at 60℃; Reagent/catalyst; UV-irradiation;62%
With oxygen In acetonitrile at 70℃; Temperature; UV-irradiation;
di-tert-butyl tricarbonate
24424-95-1

di-tert-butyl tricarbonate

L-phenylalanine
63-91-2

L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran at 60℃; for 4h;25%
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With TEA In tetrahydrofuran at 55 - 60℃;
L-phenylalanine
63-91-2

L-phenylalanine

(CCl3O)2CO

(CCl3O)2CO

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran at 55℃; for 2h;
(S)-3-phenyl-2-ureido-propionic acid
949-45-1

(S)-3-phenyl-2-ureido-propionic acid

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
With oxygen; nitrogen(II) oxide
L-phenylalanine
63-91-2

L-phenylalanine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 76 percent / aq. NaOH
2: 66.8 percent / PBr3 / diethyl ether
View Scheme
N-benzyloxycarbonyl-L-phenylalanyl chloride
52641-32-4

N-benzyloxycarbonyl-L-phenylalanyl chloride

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

Conditions
ConditionsYield
In tetrahydrofuran; hexane at 40℃; for 12h;
isopropylamine
75-31-0

isopropylamine

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-2-amino-N-isopropyl-3-phenylpropanamide
278185-22-1

(S)-2-amino-N-isopropyl-3-phenylpropanamide

Conditions
ConditionsYield
In dichloromethane at 20℃; for 0.0125h; Flow reactor;91%
In dichloromethane at 20℃; for 0.00277778h;
2-amino-4,5-dimethoxyacetophenone
4101-30-8

2-amino-4,5-dimethoxyacetophenone

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-7,8-dimethoxy-5-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

(S)-3-benzyl-7,8-dimethoxy-5-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 2-amino-4,5-dimethoxyacetophenone; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
90%
(2-aminophenyl)(phenyl)methanone
2835-77-0

(2-aminophenyl)(phenyl)methanone

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one
884492-66-4

(S)-3-benzyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: (2-aminophenyl)(phenyl)methanone; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
88%
iBu(Z-Lys)30

iBu(Z-Lys)30

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

iBu(Z-Lys)30-b-(Phe)15

iBu(Z-Lys)30-b-(Phe)15

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 24h;85%
2-Amino-5-chlorobenzophenone
719-59-5

2-Amino-5-chlorobenzophenone

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one
39200-49-2

(S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 5-chloro-2-aminobenzophenone; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
83%
2-aminoacetophenone
551-93-9

2-aminoacetophenone

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-5-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

(S)-3-benzyl-5-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 2-aminoacetophenone; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
82%
4-(2-aminobenzoyl)benzonitrile
133776-50-8

4-(2-aminobenzoyl)benzonitrile

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-4-(3-benzyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-5-yl)benzonitrile

(S)-4-(3-benzyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-5-yl)benzonitrile

Conditions
ConditionsYield
Stage #1: 4-(2-aminobenzoyl)benzonitrile; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
82%
2-amino-3-benzoyl-4,5,6,7-tetrahydrobenzo[b]thiophene
4651-72-3

2-amino-3-benzoyl-4,5,6,7-tetrahydrobenzo[b]thiophene

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-5-phenyl-1,3,6,7,8,9-hexahydro-2H-benzo[4,5]thieno[2,3-e][1,4]diazepin-2-one

(S)-3-benzyl-5-phenyl-1,3,6,7,8,9-hexahydro-2H-benzo[4,5]thieno[2,3-e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 2-amino-3-benzoyl-4,5,6,7-tetrahydrobenzo[b]thiophene; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
82%
2-amino-5-bromobenzophenone
39859-36-4

2-amino-5-bromobenzophenone

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-7-bromo-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

(S)-3-benzyl-7-bromo-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 2-amino-5-bromobenzophenone; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
79%
L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

2-mesitylmagnesium bromide
2633-66-1

2-mesitylmagnesium bromide

(S)-3-phenyl-2-(2,4,6-trimethylbenzamido)propanoic acid
79137-56-7

(S)-3-phenyl-2-(2,4,6-trimethylbenzamido)propanoic acid

Conditions
ConditionsYield
In tetrahydrofuran; diethyl ether at -78 - 20℃; for 1.33h; Inert atmosphere;75%
2-amino-5-chloro-2'-fluorobenzophenone
784-38-3

2-amino-5-chloro-2'-fluorobenzophenone

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

(S)-3-benzyl-7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 2-amino-5-chloro-2'-fluorobenzophenone; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
74%
1-(3-aminobenzofuran-2-yl)ethan-1-one
49615-96-5

1-(3-aminobenzofuran-2-yl)ethan-1-one

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-3-benzyl-5-methyl-1,3-dihydro-2H-benzofuro[3,2-e][1,4]diazepin-2-one

(S)-3-benzyl-5-methyl-1,3-dihydro-2H-benzofuro[3,2-e][1,4]diazepin-2-one

Conditions
ConditionsYield
Stage #1: 1-(3-aminobenzofuran-2-yl)ethan-1-one; L-phenylalanine-N-carboxyanhydride With trifluoroacetic acid In toluene at 60℃; for 0.5h; Sealed tube;
Stage #2: With triethylamine at 80℃; for 0.5h; Sealed tube;
68%
L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

1-phenylalanine-1-deutero-2-phenylethylamide

1-phenylalanine-1-deutero-2-phenylethylamide

Conditions
ConditionsYield
Stage #1: L-phenylalanine-N-carboxyanhydride With bis(1,5-cyclooctadiene)nickel (0); triphenylphosphine In tetrahydrofuran; diethyl ether for 24h; complexation;
Stage #2: With diclazuril In tetrahydrofuran; water-d2 acidolysis; Further stages.;
63%
methyl chloroformate
79-22-1

methyl chloroformate

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

A

2-Aminoindanone hydrochloride

2-Aminoindanone hydrochloride

B

(R)-2-p-Toluoylpyrrolidine hydrochloride

(R)-2-p-Toluoylpyrrolidine hydrochloride

Conditions
ConditionsYield
With aluminium trichloride In dichloromethane for 4h; Yields of byproduct given. Title compound not separated from byproducts;A 25%
B n/a
9-hydroxyxanthene
90-46-0

9-hydroxyxanthene

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

(S)-4-benzyl-3-xanthen-9-yl-oxazolidine-2,5-dione
108276-19-3

(S)-4-benzyl-3-xanthen-9-yl-oxazolidine-2,5-dione

Conditions
ConditionsYield
In toluene Heating;
L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

acetone oxime
127-06-0

acetone oxime

C12H16N2O2

C12H16N2O2

Conditions
ConditionsYield
With hydrogenchloride
acetophenone oxime
613-91-2

acetophenone oxime

L-phenylalanine-N-carboxyanhydride
14825-82-2

L-phenylalanine-N-carboxyanhydride

C17H18N2O2

C17H18N2O2

Conditions
ConditionsYield
With hydrogenchloride

14825-82-2Relevant articles and documents

Dual-responsive star-shaped polypeptides for drug delivery

Wang, Wenlong,Zhang, Liang,Liu, Mengtao,Le, Yuan,Lv, Shanshan,Wang, Jiexin,Chen, Jian-Feng

, p. 6368 - 6377 (2016)

Core cross-linked star-shaped polypeptides based on poly(l-glutamic acid)-poly(l-phenylalanine-co-l-cystine) copolymer have been successfully synthesized and thoroughly characterized. The star polypeptides can self-assemble to form 50 nm micelles in aqueous medium, which respond rapidly to both pH change within the physiologically relevant pH range and a reduction environment mimicking the intracellular space. Water-soluble doxorubicin hydrochloride and hydrophobic resveratrol are loaded into the star polypeptides micelles through electrostatic and hydrophobic interactions respectively. The drug loading content can be controlled by tuning the composition of the star polypeptides. The in vitro release studies indicate dual sensitivity enabled rapid drug release at pH 5.5 and 10 mM dithiothreitol (DTT), mimicking the intracellular environment. Furthermore, the star polypeptides are biocompatible and interact well with cells in vitro. Confocal fluorescence microscopy and flow cytometry assays show these star polypeptides can be quickly internalized and effectively deliver the drugs into HeLa cells to inhibit cell growth.

Investigation of N-carbamoylamino acid nitrosation by {NO + O2 in the solid-gas phase. Effects of NOx speciation and kinetic evidence for a multiple-stage process

Lagrille, Olivier,Taillades, Jacques,Boiteau, Laurent,Commeyras, Auguste

, p. 271 - 284 (2007)

Nitrosation of N-carbamoylamino acids (CAA) by gaseous NO + O2, an interesting synthetic pathway to amino acid N-carboxyanhydrides (NCA), alternative to the phosgene route, was investigated on N-carbamoyl-valine either in acetonitrile suspension or solventless conditions, and compared to the classical nitrosating system NaNO2 + CF3COOH (TFA), the latter being quite less efficient in terms of either rate, stoichiometric demand, or further tractability of the product. The rate and efficiency of the NO + O2 reaction mainly depends on the O2/NO ratio. Evaluation of the contribution of various nitrosating species (N 2O3, N2O4, HNO2) through stoichiometric balance showed the reaction to be effected mostly by N 2O3 for O2/NO ratios below 0.3, and by N 2O4 for O2/NO ratios above 0.4. The relative contribution of (subsequently formed) HNO2 always remains minor. Differential scanning calorimetry (DSC) monitoring of the reaction in the solid phase by either HNO2 (from NaNO2 + TFA), gaseous N 2O4 or gaseous N2O3, provides the associated rate constants (ca. 0.1, 2 and 108 s-1 at 25°C, respectively), showing that N2O3 is by far the most reactive of these nitrosating species. From the DSC measurement, the latent heat of fusion of N2O3, 2.74 kJ ·mol-1 at -105 °C is also obtained for the first time. The kinetics was investigated under solventless conditions at 0°C, by either quenching experiments or less tedious, rough calorimetric techniques. Auto-accelerated, parabolic-shaped kinetics was observed in the first half of the reaction course, together with substantial heat release (temperature increase of ca. 20°C within 1-2 min in a 20-mg sample), followed by pseudo-zero-order kinetics after a sudden, important decrease in apparent rate. This kinetic break is possibly due to the transition between the initial solid-gas system and a solid-liquid-gas system resulting from water formation. Overall rate constants increased with parameters such as the specific surface of the solid, the O 2/NO ratio, or the presence of moisture (or equivalently the hydrophilicity of the involved CAA), however without precise relationship, while the last two parameters may directly correlate to the increasing acidity of the medium. Copyright

Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer

Desale, Swapnil S.,Cohen, Samuel M.,Zhao, Yi,Kabanov, Alexander V.,Bronich, Tatiana K.

, p. 339 - 348 (2013)

The co-delivery of drug combination at a controlled ratio via the same vehicle to the cancer cells is offering the advantages such as spatial-temporal synchronization of drug exposure, synergistic therapeutic effects and increased therapeutic potency. In an attempt to develop such multidrug vehicle this work focuses on functional biodegradable and biocompatible polypeptide-based polymeric micelles. Triblock copolymers containing the blocks of ethylene glycol, glutamic acid and phenylalanine (PEG-PGlu-PPhe) were successfully synthesized via NCA-based ring-opening copolymerization and their composition was confirmed by 1H NMR. Self-assembly behavior of PEG-PGlu 90-PPhe25 was utilized for the synthesis of hybrid micelles with PPhe hydrophobic core, cross-linked ionic PGlu intermediate shell layer, and PEG corona. Cross-linked (cl) micelles were about 90 nm in diameter (ξ-potential = -20 mV), uniform (narrow size distribution), and exhibited nanogels-like behavior. Degradation of cl-micelles was observed in the presence of proteolytic enzymes (cathepsin B). The resulting cl-micelles can incorporate the combination of drugs with very different physical properties such as cisplatin (15 w/w% loading) and paclitaxel (9 w/w% loading). Binary drug combination in cl-micelles exhibited synergistic cytotoxicity against human ovarian A2780 cancer cells and exerted a superior antitumor activity by comparison to individual drug-loaded micelles or free cisplatin in cancer xenograft model in vivo. Tunable composition and stability of these hybrid biodegradable micelles provide platform for drug combination delivery in a broad range of cancers.

Synthesis of novel copolymer: Poly(p-dioxanone-co-l-phenylalanine)

Wang, Bing,Ma, Chi,Xiong, Zuo-Chun,Xiong, Cheng-Dong,Zhou, Quan-Hua,Chen, Dong-Liang

, p. 392 - 396 (2013)

In order to expand the application of poly(p-dioxanone) or PPDO in biomedical area, a series of novel copolymers were synthesized successfully by one-step, melted copolymerization of p-dioxanone (PDO) and l-phenylalanine N-carboxyanhydride (l-Phe-NCA) monomers. With the in-feed molar ratio of l-Phe-NCA/PDO equal to 1/20, the conversions of the two kinds of monomers were calculated from 1H NMR. The average molecular weight and polydispersity of the copolymer increase with the increasing reaction time and catalyst concentration. However, the conversions of the two kinds of monomers did not change with the reaction conditions. A three-step mechanism is presented and proved by high resolution 1H NMR and IR spectrums.

Self-assembled spin-labeled nanoparticles based on poly(amino acids)

Hubina,Pogodaev,Sharoyko,Vlakh,Tennikova

, p. 173 - 180 (2016)

The development of detectable nanoparticles for controlled drug delivery systems has tremendous practical importance regarding the monitoring of drug pathway in organism. Self-assembly amphiphilic block-copolymer poly(l-glutamic acid)-b-poly(l-phenylalanine) (pGlu-b-pPhe) was chosen for the preparation of discussed nanoparticles. The synthesis of blocks was carried out using ring-opening polymerization (ROP) of N-carboxyanhydrides of mentioned amino acids. To introduce the spin label at C-terminal position of hydrophilic block, (4-amino-2,2,6,6-tetramethylpiperidin-1-yl)oxyl (4-amino-TEMPO) was applied as ROP initiator and the polymerization of hydrophobic block was carried out with previously synthesized macroinitiator. The results obtained by transmission electron microscopy clearly showed that TEMPO-pGlu-b-pPhe polymer was really capable to self-assembling in aqueous solutions followed by polymersome formation. The mean size of nanoparticles was increased in a range of TEMPO-pGlu43-b-pPhe12 43-b-pPhe29 43-b-pPhe49 as 60 200 280 nm, respectively. EPR spectroscopy of the solutions of spin-labeled homopolymer TEMPO-p-γ-Glu(Bzl), block copolymers TEMPO-p-γ-Glu(Bzl)-b-pPhe and suspension of polymersomes formed from TEMPO-p-Glu-b-pPhe was performed and the results were compared. It was proved that in the case of nanoparticles EPR detectable spin labels are located on polymersome surface. The experiments in cell culture demonstrated the absence of cytotoxicity of labeled nanoparticles. Additionally, it was shown that TEMPO-label can be detected inside the cell by EPR method.

Synthesis of α-Amino Acid N-Carboxyanhydrides

Laconde, Guillaume,Amblard, Muriel,Martinez, Jean

supporting information, p. 6412 - 6416 (2021/08/30)

A simple phosgene- and halogen-free method for synthesizing α-amino acid N-carboxyanhydrides (NCAs) is described. The reaction between Boc-protected α-amino acids and T3P reagent gave the corresponding NCA derivatives in good yield and purity with no detectable epimerization. The process is safe, is easy-to-operate, and does not require any specific installation. It generates nontoxic, easy to remove byproducts. It can apply to the preparation of NCAs for the on-demand on-site production of either little or large quantities.

METHOD FOR PRODUCING AMINO ACID-N-CARBOXYLIC ACID ANHYDRIDE

-

Paragraph 0063-0065; 0072, (2020/08/07)

PROBLEM TO BE SOLVED: To provide: a method for safely and efficiently producing amino acid-N-carboxylic acid anhydride; and a method for producing peptide by using the obtained amino acid-N-carboxylic acid anhydride. SOLUTION: The method for producing an amino acid-N-carboxylic acid anhydride according to the present invention is characterized in that the amino acid-N-carboxylic acid anhydride is represented by the following formula (II), and a step of irradiating a composition containing a halogenated methane and an amino acid compound represented by the following formula (I) with high energy light in the presence of oxygen is included. [In the formula, R1 represents an amino acid side chain group in which the reactive group is protected, and R2 represents H or the like.]. SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT

Formamide catalyzed activation of carboxylic acids-versatile and cost-efficient amidation and esterification

Huy, Peter H.,Mbouhom, Christelle

, p. 7399 - 7406 (2019/08/20)

A novel, broadly applicable method for amide C-N and ester C-O bond formation is presented based on formylpyrrolidine (FPyr) as a Lewis base catalyst. Herein, trichlorotriazine (TCT), which is the most cost-efficient reagent for OH-group activation, was employed in amounts of ≤40 mol% with respect to the starting material (100 mol%). The new approach is distinguished by excellent cost-efficiency, waste-balance (E-factor down to 3) and scalability (up to >80 g). Moreover, high levels of functional group compatibility, which includes acid-labile acetals and silyl ethers, are demonstrated and even peptide C-N bonds can be formed. In comparison to reported amidation procedures using TCT, yields are considerably improved (for instance from 26 to 91%) and esterification is facilitated for the first time in synthetically useful yields. These significant enhancements are rationalized by activation by means of acid chlorides instead of less electrophilic acid anhydride intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14825-82-2